key: cord-1036219-05jp48x8 authors: Abdel Rhman, Samir Shokr; Abdel Wahid, Assem Ali title: COVID -19 and sudden sensorineural hearing loss, a case report date: 2020-07-08 journal: nan DOI: 10.1016/j.xocr.2020.100198 sha: a999bba8868aba51f05af22405871669a1cd685b doc_id: 1036219 cord_uid: 05jp48x8 nan The Coronavirus disease-2019"COVID-19" pandemic is caused by novel Corona Virus-2019 (nCoV-19). The outbreak was identified in Wuhan, China, in December 2019 [1] . The World Health Organization has declared the outbreak a Public Health Emergency of International Concern on 30 January and a pandemic on 11 March 2020 [2] . As of 1 may 2020, more than 3.5 million cases of COVID-19 have been reported in over 187 countries and territories, resulting in more than 250,000 deaths [3] . The clinical symptoms of this disease may appear 2-14 days after exposure (based on the incubation period of COVID-19 virus). These symptoms include fever, sore throat, cough, myalgia and some patients had gastrointestinal infection symptoms [4] . The elderly people with comorbidity are more susceptible to infection and prone to serious outcomes, which may be associated with acute respiratory distress syndrome (ARDS). Neurological symptoms such as sudden loss of smell and taste also was reported in a significant number of COVID-19 patient [1&5]. Sudden sensorineural hearing loss (SSNHL) is defined as sensorineural hearing loss of 30 dB or greater in at least three consecutive frequencies occurring over 72 hours. Some viral infections can cause SSNHL that can be congenital or acquired, unilateral or bilateral. Viral infections has been proposed as a cause of SSNHL through damage of inner ear structures or by precipitating inflammatory responses which then cause this damage[4&6]. A written informed consent has been obtained from the study participant. On April 11 a 52-year-old male physician declared close contact with a confirmed COVID-19 case. He was isolated and nasopharyngeal swab for nCoV-19 PCR was obtained. On April 15 PCR result was obtained and it was positive for nCoV-19. 3 days later he was referred to ENT clinic because he complained of sudden onset left-sided hearing loss that was preceded by gradually worsening tinnitus. The patient has no ear pain, discharge, dizziness nor vertigo. He had no history of head trauma or ototoxic medications during isolation. Otoscopic examination revealed bilateral normal external auditory canals and tympanic membranes. Tunning for tests demonstrated bilateral positive Renne test while Webber test lateralized to right side. There was no other focal neurological deficit. The patient was discharged on April 26 after two negative respiratory swabs. Audiometry was done that revealed right normal hearing level and left severe sensorineural hearing loss (image 1) with bilateral type A impedance audiometry. Full blood count was normal, CPR was high (27.81) while viral serology markers for cytomegalovirus, HIV, hepatitis B and C and syphilis serology were negative. Autoimmune screening was performed and it was also negative for antinuclear antibodies. Pre and post contrast MRI of the brain revealed normal intracranial appearances; specifically, no abnormalities were seen at the internal auditory meatus or cerebellopontine angles. Intra-tympanic injection of corticosteroid (methylprednisolone 40 mg/ml) under local anesthesia was carried out on three sessions with 5 days apart [7&8]. Follow up pure tone audiometry done one week after last session of intratympanic injection that revealed improvement of hearing level (image 2). The patient was scheduled for another session of intra-tympanic injection and his general condition was very good. In this case, the patient did not present by the typical characteristics symptoms of COVID-19 like fever, cough, expectoration, but sudden loss of hearing was the only presenting symptom. In addition, no abnormal laboratory or radiological testing (except positive PCR for COV-1 9 and high CRP, mostly due to COVID19 infection) that could explain the cause of such hearing loss. SSNHL is an emergent otolaryngology disorder and early management is required, but there was a great challenge because Up to the time of writing this case report, there is little documenting how otolaryngology departments should approach otolaryngologic diseases in patients infected with COVID-19. For the management of this case we preferred intra-tympanic corticosteroid injection as there is controversy about the use of systemic steroid in the treatment of COVID-19 patients. Mostafa MWM has conducted a study to compare the amplitude of transient evoked otoacoustic emissions and latencies of vestibular evoked myogenic potentialsbetween asymptomatic COVID-19 PCR-positive patients and normal non-infected subjects and concluded that COVID-19 infection could have deleterious effects on cochlear hair cell functions [9] . Sriwijitalaia W and Wiwanitkitb V preliminary reported that acase, an old female, has sensorineural hearing loss was recorded in Thailand and she was cared by standard respiratory care and recovery with no observation on change of hearing loss problem [10] Conclusion COVID-19 should be taken into consideration in patients presented with sudden hearing loss nowadays. Much work up for understanding the pathogenesis and auditory complications of this challenging disease still extremely needed next days. We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual propefi associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. ln so doing we confirm that we have followed the regulations of our i nstitutions concerning intellectua I property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. We understand that the Corresponding Author is the sole contact for the Editorial process including Editorial Manager and direct communications with the office). He is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept emailfrom the editor. Naming the coronavirus disease (COVID-19) and the virus that causes it Clinical features of patients infected with 2019 novel coronavirus in Wuhan COVID-19 Dashboard by the Archived from the original on 30 Coronavirus Disease 2019 (COVID-19 Sudden sensorineural hearing loss Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis Sudden Hearing Loss Audiological Profile of Asymptomatic Covid-19PCR-positive Cases Hearing loss and COVID-19: a note The authors whose names are listed immediately above certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript Yours Sincerely,Author (1)